Xencor, Inc.
XNCRNext catalyst
Data Readout — XmAb819
Get an email about XNCR's next catalysts
Track Xencor (XNCR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 1 past
XNCR Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.35 | FQ end Sep/2026 | Call: tbd
Data Readout — XmAb819
Xencor plans to present XmAb819 data and expects XmAb942 interim data readout by end of 2026. The article indicates positive sentiment toward the company's pipeline progress.
SourceMarket Overview
Stock performance and key metrics
XmAb5871
Systemic Lupus Erythematosus
vudalimab monotherapy
Metastatic Castration-Resistant Prostate Cancer
vudalimab
Ovarian Cancer
XmAb942
Ulcerative Colitis (UC)
XmAb20717
Biliary Tract Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
XmAb5871 | Phase 2 | Systemic Lupus Erythematosus | - | - |
vudalimab monotherapy | Phase 2 | Metastatic Castration-Resistant Prostate Cancer | - | - |
vudalimab | Phase 2 | Ovarian Cancer | - | - |
XmAb942 | Phase 2 | Ulcerative Colitis (UC) | - | - |
XmAb20717 | Phase 2 | Biliary Tract Cancer | - | - |
Systemic Lupus Erythematosus
1 drug in this indication
Ovarian Cancer
1 drug in this indication
Metastatic Castration-Resistant Prostate Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Xencor, Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in Xencor, Inc.'s (XNCR) pipeline across Phase 2. Its lead program is vudalimab (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Xencor, Inc.'s next FDA catalyst?→
Xencor, Inc.'s (XNCR) next tracked catalyst is a data readout expected Dec 31, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track XNCR biotech catalysts?→
Add XNCR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Xencor, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.